MARC details
| 000 -LEADER |
|---|
| fixed length control field |
06379cam a2200421 a 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
17688225 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20240305192016.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
130329s2013 nju b 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER |
|---|
| LC control number |
2013013054 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780470621882 (hardback : alk. paper) |
|
|---|
| International Standard Book Number |
9781118590607 (pub) |
|
|---|
| International Standard Book Number |
9781118590614 (PDF) |
|
|---|
| International Standard Book Number |
9781118590621 (Mobi) |
|
|---|
| International Standard Book Number |
9781118590638 (online product) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(DNLM)101605168 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
DNLM/DLC |
| Transcribing agency |
DLC |
| Modifying agency |
DLC |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
pcc |
| 050 00 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RC280.S5 |
| Item number |
D47 2013 |
| 060 10 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER |
|---|
| Classification number |
WR 140 |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.99/477 |
| Edition information |
23 |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Dermatologic principles and practice in oncology : |
| Remainder of title |
conditions of the skin, hair, and nails in cancer patients / |
| Statement of responsibility, etc. |
[edited by] Mario E. Lacouture. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Hoboken, N.J. : |
| Name of publisher, distributor, etc. |
Wiley-Blackwell, |
| Date of publication, distribution, etc. |
c2013. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
x, 430 p. ; |
| Dimensions |
29 cm. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 505 8# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Machine generated contents note: Section 1 Dermotology and Oncology 1 Epidemiology and Burden of Disease / Beth McLellan and Mario E. Lacouture -- 2 The History of Supportive Oncodermatology / Yevgeniy Balagula1, Steven T. Rosen and Mario E. Lacouture -- 3 Structure and Function of the Integumentary System and the Dermatology Lexicon / Emmy Garber and Amit Garg -- Types of dermatologic reactions / Raed O. Alhusayen, Sandra R. Knowles and Neil H. Shear -- 5 Grading Dermatologic Adverse Events on Clinical Trials using CTCAE v4.0 / Alice Chen, Asha Acharya and Ann Setser -- 6 Psychosocial Issues in Oncology: Clinical management of psychosocial distress, health-related quality of life and special considerations in dermatologic oncology / Lynne I. Wagner and David Cella -- 7 Dermatopathology / James L. Troy and Molly Hinshaw -- Section 2 Cancer-Related Dermatologic Disorders / Cindy England Owen and Jeffrey P. Callen -- Section 3 Dermatologic Conditions During Cancer Therapy 9 ORAL MUCOSAL COMPLICATIONS OF CANCER THERAPY / Stephen T. Sonis -- 10 Hair Disorders Associated with Anticancer Agents / Caroline Yeager and Elise A. Olsen -- 11 NAIL ABNORMALITIES IN ONCOLOGY PRACTICE / Robert Baran, Bernard Fouilloux and Caroline Robert -- 12 Pruritus / Tejesh Patel and Gil Yosipovitch -- 13 Management Options for Hot Flashes in Cancer Patients / Amanda R. Moraska and Charles L. Loprinzi -- Section 4 Skin toxicities due to chemotherapy 14 Alkylating agents (Busulfan, ThioTEPA, Mechlorethamine, Melphalan, Chlorambucil, cyclophosphamide, ifosfamide, carmustine, streptozocin, dacarbazine, temozolomide, etoposide,BCNU) / Elisabeth Livingstone, Lisa Zimmer, Larissa Schottler, Dirk Schadendorf1 -- 5 Antimetabolite Reactions (Methotrexate, pemetrexed, capecitabine, cytarabine, gemcitabine, 6MP, 6-TG, fludarabine, cladribine) / Emily Y. Chu and Heidi H. Kong -- 16 Topoisomerase-interacting agents (irinotecan, topotecan, doxorubicin, daunorubicin,epirubicin, idarubicin, mitoxantrone, dactinomycin, etoposide, teniposide) / Tomas Skacel, Roger von Moos and Reinhard Dummer -- 17 Epidermal Growth Factor Receptor Inhibitor Reactions / Yevgeniy Balagula and Mario E. Lacouture -- 18 Small Molecule Kinase Inhibitors / Caroline Robert, Vincent Sibaud and Christine Mateus -- 19 Antimicrotubule agents (Paclitaxel, docetaxel, albumin-bound paclitaxel, vincristine, vinblastine, vi-norelbine, estramustine) / Claus Garbe -- 20 Histone Deacetylase Inhibitors (HDAC inhibitors) Proteasome inhibitors Demethylating Agents Arsenicals Retinoids / Najla Al-Dawsari, Shannon Campbell and Francine Foss -- 21 Miscellaneous Reactions (L-Asparaginase, bleomycin, thalidomide, lenalidomide) / Katharina C. Kaehler, Christine B. Boers-Doets, Mario E. Lacouture and Axel Hauschild -- 22 Skin toxicities due to biotherapy (Interferon-[alpha]2b, Interleukin-2) / Axel Hauschild, Katharina Kaehler and Mario Lacouture -- 23 Monoclonal antibodies / Caroline Robert -- 24 Endocrine Agents / Katherine Szyfelbein and Mario Lacouture -- 25 Agents for the management of hematologic reactions: epotein alpha, darbopoetin, G-CSF, GM-CSF; oprelvekin; low molecular weight heparin; warfarin. / Mee-young Lee and Caroline C. Kim -- 26 RDERMATOLOGICAL PRINCIPLES AND PRACTICE IN ONCOLOGY / Rebecca Wong and Zahra Kassam -- 27 Hematopoietic stem cell transplantation and graft-versus-host disease / Stephanie Hu and Jonathan Cotliar -- 28 Extravasation Reactions / Seppo W. Langer -- 29 Topical Anticancer Therapies / Patricia L. Myskowski -- 30 Life-threatening (Serious) Dermatologic Adverse Events / Milan Anadkat -- 31 Dermatologic infections / Yevgeniy Balagula, Mario E. Lacouture and James I. Ito Section 5 -- 32 Late Dermatologic Conditions / Jennifer Namchoi Section 6 Dermatologic Practice in Oncology 33 Management Algorithms for Dermatologic Adverse Events / Alyx Rosen, Iris Amitay-Laish and Mario E. Lacouture -- 34 Dermatological therapeutics and formulations / Judy H. Borovicka, Jennifer R.S. Gordon, Ann Cameron Haley and Dennis P. West35 Dermatological Techniques and Procedures / Kishwer Nehal, Erica Lee and Robert Eilers -- 36 Appearance-Related Concerns in the Cancer Patient / Amy J. Derick. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc. |
"This is the first book to focus on frequent and frequently disabling side effects involving the skin, hair, and nails in cancer patients. It provides detailed descriptions of mechanism-of-action in all current oncology drugs and the clinical presentation and mechanisms underlying their dermatologic side effects, alongside carefully presented treatment recommendations, allowing physicians to significantly enhance their care of patients with cancer. Whereas existing oncology and dermatology textbooks only briefly deal with this topic, this resource offers dermatologists and other practitioners a focused perspective on cancer-related skin conditions"-- |
| Assigning source |
Provided by publisher. |
| 650 12 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| General subdivision |
etiology. |
| 9 (RLIN) |
12640 |
|
|---|
| General subdivision |
psychology. |
| 9 (RLIN) |
12641 |
|
|---|
| General subdivision |
adverse effects. |
| 9 (RLIN) |
12642 |
|
|---|
| General subdivision |
complications. |
| 9 (RLIN) |
8454 |
|
|---|
| General subdivision |
nursing. |
| 9 (RLIN) |
12643 |
|
|---|
| 9 (RLIN) |
1503 |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| 9 (RLIN) |
12644 |
| 906 ## - LOCAL DATA ELEMENT F, LDF (RLIN) |
|---|
| a |
7 |
| b |
cbc |
| c |
orignew |
| d |
1 |
| e |
ecip |
| f |
20 |
| g |
y-gencatlg |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
ddc |
| Koha item type |
E-BOOKS |
